Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celgene Corporation Elects Ernest Mario to Board of Directors.


SUMMIT, N.J. -- Celgene Corporation (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: CELG) announced the election of Ernest Mario Ernest Mario (born June 12, 1938, Clifton, New Jersey) is an American pharmaceutical industry executive and the recipient of the 2007 Remington Medalist awarded by the American Pharmacists Association. , Ph.D. to the Company's Board of Directors. Dr. Mario is an experienced corporate director with a distinguished career in global healthcare. Dr. Mario has served as Deputy Chairman and Chief Executive of Glaxo Holdings plc., one of the largest and most successful multi-national healthcare companies in the world. Also, Dr. Mario served as Chairman and Chief Executive Officer of ALZA Corporation, a research based global pharmaceutical company with leading drug delivery technologies.

"We are delighted that a dynamic and experienced leader like Ernest Mario is joining our board of directors," said Sol. J. Barer, Ph.D., Chairman and Chief Executive Officer of Celgene Corporation. "His healthcare and business acumen will contribute greatly to our global objective to maximize the potential of Celgene worldwide."

Dr. Mario has been a Director of Boston Scientific The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions,  since October 2001 and is currently Chairman of Pharmaceutical Product Development. From 2003 to 2007, he was Chairman and Chief Executive of Reliant Pharmaceuticals. Dr. Mario was recently appointed the Chief Executive Officer of Capnia, Inc.

A former Trustee of Duke University, he serves on the Board of the Duke University Health System. He is a past Chairman of the American Foundation for Pharmaceutical Education and serves as an advisor to the pharmacy schools This article is a list of pharmacy schools by country. List
Argentina
  • National University of Buenos Aires - Faculty of Pharmacy and Biochemistry
  • National University of Cordoba - Department of Pharmacy
  • John F.
 at the University of Maryland University of Maryland can refer to:
  • University of Maryland, College Park, a research-extensive and flagship university; when the term "University of Maryland" is used without any qualification, it generally refers to this school
, the University of Rhode Island History
The University was first chartered as the state's agricultural school in 1888. The site of the school was originally the Oliver Watson Farm, and the original farmhouse still lies on the campus today.
 and The Ernest Mario School of Pharmacy Ernest Mario School of Pharmacy is a part of Rutgers University. The facilities are housed in William Levine Hall on Busch Campus in Piscataway, New Jersey. It was founded in 1892 as the Newark College of Pharmacy and then absorbed into Rutgers University in 1927  at Rutgers University. Recipient of the 2007 Remington Medal, pharmacy's highest honor, Dr. Mario holds a B.S. in Pharmacy from Rutgers, and an M.S. and a Ph.D. in Physical Sciences from the University of Rhode Island.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the Company's website at www.celgene.com.

This release contains forward-looking statements which are subject to known and unknown risks, delays, uncertainties and other factors not under the Company's control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. These factors include results of current or pending research and development activities, actions by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 and other regulatory authorities, and other factors described in the Company's filings with the Securities and Exchange Commission such as our 10K, 10Q and 8K reports.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 23, 2007
Words:421
Previous Article:GameStop Reports Record Second Quarter 2007 Results.
Next Article:Command Security Corporation Awarded $3.1 Million in Security Services Contracts.
Topics:



Related Articles
Scholastic Coach, 75 years of leadership and service.
School board member resigns.
`Love Tour' leaves some singing the blues.
Lehman Bros. grows to 270,000 s/f at Mack-Cali's Jersey City tower.
Media firm takes W44th St penthouse.
Pharmacy takes Lex.
Sale at 82 Totowa Rd. marks one of few industrial trades this year.
Corporation takes Princeton space.
Sky chief announces Marquis partnership.
IDA cash aid helping companies expand.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles